EMAIL US AT info@aldconnect.org
CALL US NOW (833) 525-3266

ABOUT US

About Us

We are a 501(c)3 non-profit organization focused on improving the quality of life for those living with ALD and AMN through research, advocacy and family support. We believe we can accomplish our mission by pursuing the following initiatives to:

  • Fund research to advance treatment and to find a cure
  • Raise awareness, and promote education
  • Advocate for newborn screening
  • Provide financial support to low-income families

The Myelin Project was established in 1989 by Augusto and Michaela Odone for their son Lorenzo who suffered from adrenoleukodystrophy (ALD), a rare genetic disease that deteriorates myelin in the brain and central nervous system. Although not medical doctors, the Odones went on an investigative journey into the disease and were able to develop an oil treatment that has proven to slow the progress of the disease – and they named it Lorenzo’s Oil – which has now become an internationally recognized treatment, yet still not approved by the US FDA.  The story of the Odones’ struggle was dramatized in George Miller’s 1992 film Lorenzo’s Oil starring Nick Nolte and Susan Sarandon.

RESEARCH

ADVOCACY

FAMILY SUPPORT

Adrenoleukodystrophy (ALD) is a rare x-linked genetic brain disease that affects roughly 1 in 15,000 people. It has four different forms, or phenotypes. The most devastating appears in childhood, generally between the ages of four and ten years old. Normal, healthy boys suddenly regress rapidly. Symptoms begin with hyperactivity, withdrawal, and/or difficulty concentrating. As the disease continues to destroy myelin in the brain and nervous system, symptoms grow worse including blindness, deafness, seizures, loss of muscle control, and progressive dementia. Often this leads to either death or permanent disability usually within 2 to five years of diagnosis.

Adrenomyeloneuropathy (AMN) is the adult onset of adrenoleukodystrophy (ALD). In about half of the boys who inherit the mutated ALD gene, symptoms of the disease do not develop until young adulthood, and in general, they progress more slowly. Beginning in their 20s and 30s, these young men exhibit neurological based motor lesions in their extremities. These lesions progress over many years and are inevitably accompanied by moderate to severe handicap and in many cases, these symptoms lead to death.

OUR TEAM

Gianvito-Martino

Dr. Gianvito Martino

Scientific Adviser
Annick-Baron

Dr. Annick Baron

Scientific Adviser
Wolfgang-Bruck-1-e1457382751379

Dr. Wolfgang Brück

Scientific Adviser
Robin-Franklin-1

Dr. Robin Franklin

Scientific Adviser
kocsis268

Dr. Jeffery Kocsis

Scientific Adviser
charles_ffrenchconstant

Dr. Charles ffrench-Constant

Scientific Adviser
Patti-Chapman-1

Patricia L. Chapman

President, Board Chair
Greg-HeadShot

Greg Benton

Program Director & Marketing Manager
Deb Edwards

Deb Edwards

TREASURER
Duncan-1-e1457455633992

Dr. Ian D Duncan

Scientific Adviser
keith-p-van-haren-e1457387777264

Dr. Keith Van Haren

Clinical Adviser
Justin D’Agostino

Justin D’Agostino

Board Member, Patient Liaison

My 11 year old son has ALD. He underwent a bone marrow transplant in 2014 and I had to quit my job to be with him. The Myelin Project’s family support program put food on our table and made sure our power and water stayed on.

Mollie H.

Client Served

Thank you for the teaching packet for ALD and Lorenzo’s Oil. I will be using this packet with my Associate Degree RN students in their Pediatric Nursing Course. Having the pathophysiological as well as the ethical component allows me to engage my students on many levels.

Ellen K.

PROFESSOR

I have shown Lorenzo’s Oil to my advanced chemistry students for years. It is a powerful way to teach chemistry, biology and chemistry. Thank you very much!

Todd H.

Teacher

OUR PARTNERS

NEWSLETTER SIGN-UP

News, events, and more...